Literature DB >> 901997

Staging breast cancer: role of bone scanning.

C J Davies, P A Griffiths, B J Preston, A H Morris, C W Elston, R W Blamey.   

Abstract

Bone scans using technetium-99m phosphate complexes and a rectilinear scanner were carried out on 192 women with primary operable breast cancer four to six weeks after operation. The lymph node status of all these patients was assessed histologically from triple node biopsy specimens. Only nine patients had positive scans, although 94 patients had histological evidence that the tumour had already spread beyond the confines of the breast. Bone scanning, although accurate as a prognostic guide, is helpful only in a very few cases, and serves mainly to confirm prognostic information obtained more simply and less extensively by histological examination of lymph node biopsy specimens.

Entities:  

Mesh:

Year:  1977        PMID: 901997      PMCID: PMC1631543          DOI: 10.1136/bmj.2.6087.603

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  Does early detection of bone metastases by scanning improve prognosis in breast cancer?

Authors:  J S Blair
Journal:  Clin Oncol       Date:  1975-09

2.  Radioactive technetium phosphate bone scanning in preoperative assessment and follow-up study of patients with primary cancer of the breast.

Authors:  D L Citrin; C M Furnival; R G Bessent; W R Greig; G Bell; L H Blumgart
Journal:  Surg Gynecol Obstet       Date:  1976-09

3.  Metastatic bone disease developing in patients with potentially curable breast cancer.

Authors:  G F Robbins; W H Knapper; J Barrie; I Kripalani; J Lawrence
Journal:  Cancer       Date:  1972-06       Impact factor: 6.860

4.  Skeletal metastases and mammary cancer.

Authors:  C S Galasko
Journal:  Ann R Coll Surg Engl       Date:  1972-01       Impact factor: 1.891

5.  Bone metastases from breast cancer at the time of radical mastectomy.

Authors:  D M Sklaroff; N D Charkes
Journal:  Surg Gynecol Obstet       Date:  1968-10

6.  Evaluation of radiography and isotopic scintigraphy for detecting skeletal metastases in breast cancer.

Authors:  J G Roberts; I H Gravelle; M Baum; A S Bligh; K G Leach; L E Hughes
Journal:  Lancet       Date:  1976-01-31       Impact factor: 79.321

7.  The clinical role of skeletal scanning.

Authors:  P J Ell
Journal:  Ann R Coll Surg Engl       Date:  1975-12       Impact factor: 1.891

8.  The significance of occult skeletal metastases, detected by skeletal scintigraphy, in patients with otherwise apparently 'early' mammary carcinoma.

Authors:  C S Galasko
Journal:  Br J Surg       Date:  1975-09       Impact factor: 6.939

  8 in total
  4 in total

1.  Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money.

Authors:  K A Yeh; L Fortunato; J A Ridge; J P Hoffman; B L Eisenberg; E R Sigurdson
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

2.  Radionuclide evaluation of skeletal metastases: practical considerations.

Authors:  R H Gold; L W Bassett
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

3.  CA15-3: a reliable indicator of metastatic bone disease in breast cancer patients.

Authors:  D P O'Brien; P G Horgan; D B Gough; R Skehill; H Grimes; H F Given
Journal:  Ann R Coll Surg Engl       Date:  1992-01       Impact factor: 1.891

Review 4.  Skeletal scintigraphy.

Authors:  I R McDougall
Journal:  West J Med       Date:  1979-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.